The ICM+ software, developed by Dr Peter Smielewski and Professor Marek Czosnyka, provides for real-time multimodality monitoring, analysis and data storage in neurological intensive care environments. Download further information here.
Non-exclusive licences with standard terms and conditions are available for the ICM+® software. Licence types include our standard, single centre research licence (usually priced at £7,500 plus VAT if applicable) that allows the software to be installed on up to 15 PCs per department (if you wish to install the software on more than 15 PCs then additional costs may be levied). We also offer consortium (i.e. multi-centre) as well as project-specific licensing (fees generally range from £4,000 to £7,500 plus VAT if applicable per centre). Offline and evaluation licences are also available.
To obtain a licence tailored to your needs:
- Complete the Licence Request Form and email it to email@example.com
- We will then send you a custom proposal for the licence (as well as custom consultancy work if requested).
- If you wish to proceed, we’ll draft a licence (and consultancy agreement if requested) and send it to you.
- The licence (and consultancy agreement if requested) will need to be signed by both an authorised official at your organisation and by the head of the research group requesting the software. Agreements can be executed by PDF or hard copy.
- Depending on the terms of the licence, the ICM+® software can then be installed either remotely (no additional charge) or via an on-site visit (charged separately); we will then invoice you thereafter.
- Maintenance updates are usually provided for two years as part of the license fee via the ICM+® website. Should you wish to continue downloading maintenance updates after the initial two year period, a separate Maintenance Agreement can be put in place at a cost of £770 (plus VAT if applicable) which will provide two further years of maintenance updates, plus one day of remote support.
Please note: The ICM+® software is in a development stage and is provided ‘as is’ (i.e. it is not error-free). ICM+® is designed as a research tool in order to augment clinical research; it is not licensed for diagnostic, therapeutic or clinical decision-making purposes. ICM+® has not been approved for use by any regulatory authority.
Third party Add-ons
- ICM+ Tools: a separate add-on tool called to assist with the management of data resulting from the use of ICM+® is available from Monash University.
- nICP plug-in: a separate plug-in for ICM+® that enables non-invasive calculation of ICP from TCD FV and ABP signals in real time is available from Bernhard Schmidt at Klinikum Chemnitz.
These third party providers are listed strictly for information purposes only. Cambridge Enterprise is not responsible for the quality of the software, goods or services offered by these providers.
Make an Enquiry